Objective: Improved outcomes after pancreatic resection (PR) by high volume (HV) surgeons have been reported in single center studies, which may be confounded with potential selection and referral bias. We attempted to determine if improved outcomes by HV surgeons are reproducible when patient demographic factors are controlled at the population level. Methods: Using the Nationwide Inpatient Sample, discharge records with surgeon identifiers for all nontrauma PR (n ϭ 3581) were examined from 1998 to 2005. Surgeons were divided into 2 groups: (HV; Ն5 operations/ year) or low volume (LV; Ͻ5 operations/year). We created a logistic regression model to examine the relationship between surgeon type and operative mortality while accounting for patient and hospital factors. To further eliminate differences in cohorts and determine the true effect of surgeon volume on mortality, case-control groups based on patient demographics were created using propensity scores. Results: One hundred thirty-four HV and 1450 LV surgeons performed 3581 PR in 742 hospitals across 12 states that reported surgeon identifier information over the 8-year period. Patients who underwent PR by HV surgeons were more likely to be male, white raced, and a resident of a high-income zip code (P Ͻ 0.05). Significant independent factors for in-hospital mortality after PR included increasing age, male gender, Medicaid insurance, and surgery by HV surgeon. HV surgeons had a lower adjusted mortality compared with LV surgeons (2.4% vs. 6.4%; P Ͻ 0.0001). Conclusions: After controlling for patient demographics and factors, pancreatic resection by a HV surgeon in this case-controlled cohort was independently associated with a 51% reduction in in-hospital mortality. (Ann Surg 2009;249: 635-640) 
T he volume-outcome relationship has demonstrated improved outcomes by high volume (HV) surgeons in many areas of surgery. The stakes of improved outcomes may be highest for complex surgery as poor outcome is frequently synonymous with mortality. This relationship has specifically been established with respect to complicated surgical procedures including: carotid endarterectomy, coronary-artery bypass grafting, aortic valve replacement, elective repair of abdominal aortic aneurysm, resection for lung cancer, esophagectomy, and pancreatic resection (PR). [1] [2] [3] [4] In vascular surgery, a direct relationship has been shown between surgeon caseload and prevention of morbidity, complications, and mortality. 5 This confirms traditional thinking that suggests that experience generally garners surgical expertise. However, the "prac-tice makes perfect" mantra of surgical outcomes has been challenged as some argue patient factors equally affect outcome. 6, 7 Patients who have more comorbid disease may have worse outcomes in surgery, which may be independent of the expertise of the surgeon. 8 Outcome in surgery may be more of a reflection of the interplay between surgeon, hospital, and patient factors. Many studies that have been published to date have not accounted for demographic and treatment differences in cohorts, which may lead to assumptions that do not account for disparities within the cohorts. 9 -12 Because the interaction between patient, hospital factors, surgical volume, and expertise has not been well studied, we aimed to investigate this in a population-based analysis. By controlling for patient and demographic factors of PR, we were able to isolate and examine the independent effect of surgeon volume on outcome using PR as a model.
METHODS
A retrospective analysis was performed using discharge records from the Nationwide Inpatient Sample (NIS) from 1998 to 2005 for all patients who underwent PR for which surgeon identifiers were available. The NIS is the largest United States all-payer database for inpatient medical records constituting 20% of hospital discharges. The Healthcare Cost and Utilization Project supports the database, which contains all patient discharge records from participating hospitals. Seven million hospital discharges per year are compiled from one-fifth of nonfederal community hospitals including both academic and specialty hospitals. This study was reviewed by and received exemption from the University of Massachusetts Institutional Review Board, as no personal identifiers are listed in the NIS data.
Study Population
The Clinical Modification of the International Classification of Diseases, 9th Revision (ICD-9-CM) diagnostic and procedural codes was used to identify the cohort. PR was defined as distal pancreatectomy (52.52) or pancreaticoduodenectomy (52.7) for any cause in this study. The purpose of limiting to these 2 procedures was to ensure that major resections were performed at adequate volume that would allow us to compare the differences and influence on other factors between procedures. Patients who underwent PR were identified and included only if hospital and surgeon identifier data were available. These states included FL, IA, MD, ME, NH, NJ, NV, NY, PA, SD, TX, and VA for at least one year over the course of the study (Fig. 1 ). This comprised 3581 of 13,087 total PR (27.4%) performed in the NIS over the 8-year period. We excluded patients with an admission type of "newborn" and "trauma," both of which comprised less than 0.2% (n ϭ 7) of the total cohort.
To evaluate volume, we categorized groups based on approximately equal sizes for purposes of comparison before any volumeoutcome data analysis, as previously described. 1, 2, 13 Surgeons were grouped as either HV if they performed Ն5 PR in a given year or low volume (LV) if they performed Ͻ5 PR in a given year. Using the Leapfrog cut-off for PR, hospitals were defined as HV if a center performed Ն11 PR per year. 14
Provider Identifiers
Surgeon identifiers were used to determine the number of PR per individual surgeon. Because record sampling in the NIS does not correlate across years, a continuous single surgeon identifier was not possible. Each record or identifier is considered a unit assigned to a specific surgeon or hospital. Therefore, the same surgeon may operate in different years recorded as a different individual surgeon but the physician identifier does not change within a given year. For example, due to the sampling in the NIS, it is possible for a surgeon's hospital to be included in one year and then not included the following year. Because of the variable for surgeon identifier changing twice during the study period, and to concerns regarding the fidelity of surgeon identifiers from year to year, all volume calculations were done on a year-to-year basis. Extrapolation of the dataset using institutional weighting was not performed. To create equal cut-off groups, HV surgeons were defined as Ն5 PR/year. Each "surgeon" represents a surgeon/year grouping given the lack of continuity from year to year. For further analysis, surgeon volume was also examined in increasing increments of 5 PR per year.
Variables
Patient demographic characteristics compiled in the NIS were used. Age was incorporated as a continuous variable. Race was categorized by the following groups: white, black, Hispanic, or other (Asians, Pacific Islanders, and Native Americans). Race was missing in 8.0% of cases in this cohort. Income bracket, a categorical variable, was created by using the corresponding median household income from the respective residential zip code. For the years 1998 to 2002, quartiles were created based on demographics from 1999 where the maximum of the first quartile equaled 150% of the poverty level, and the second and third quartiles were divided using the national median income as the upper limit of the second quartile. For the years 2003 to 2005 annual adjustments were made to separate patients equally with the same division between the second and third quartile. Four payer status groups were created including: Medicare, Medicaid, private insurance, or other.
To evaluate comorbidity, the Elixhauser comorbidity index was used. 15 This previously validated index identifies 29 specific disease entities that are considered true preoperative comorbidities rather than complications of care. Scores between 0 and 3 were created based on how many comorbid diseases patients had.
Outcomes
In-hospital mortality was the primary end point examined in this study and was defined as death due to any cause before discharge.
Because the level of complexity varies from distal pancreatectomy and pancreaticoduodenectomy, separate analyses were performed for each procedure to confirm that the same volume relation persists for each group that comprises PR.
Case-Controlled Analysis
Propensity scores were used to further investigate whether differences in outcomes between HV and LV surgeons were dependent on differences in patient population and disease characteristics as previously described. 9, 10, 16, 17 Candidate factors for the propensity model included available demographic and disease factors. This included age, gender, race, insurance type, income bracket, admission type, procedure, malignant diagnosis, and Elixhauser comorbidity count. A matched cohort was created in which all demographic/disease characteristic differences between HV and LV surgeons (n ϭ 1210 in each group) were eliminated, allowing us to evaluate the effect of volume on mortality in a case-control fashion. Within each group, the association between each demographic or disease characteristic was determined by the 2 test or student t test. SAS 8 .02 software (SAS Institute, Cary, NC) was used to analyze data. The Shapiro-Wilks test was used to evaluate continuous variables for normality. One-way analysis of variance was used to determine statistical significance. 2 analysis tested categorical variables. Statistical significance was defined as P Ͻ 0.05. Continuous variables are presented as median and range.
Statistical Analysis
Univariate predictor variables with a P Ͻ 0.10 were included in the multivariate analysis. The effect of PR on the probability of in-hospital mortality, while controlling for confounding variables was accomplished using a logistical regression. A Hosmer-Lemeshow goodness-of-fit test confirmed the model. Variables assessed by logistical regression included: age (continuous), sex, race (white, black, Hispanic, or other), primary insurance (Medicare, Medicaid, private, or other), admission type (elective or emergent/urgent), Elixhauser comorbidity score, malignant diagnosis, and volume status. The model was analyzed with and without surgeon volume and then hospital volume to assess their impact individually and to determine the level of confounding between surgeon and center. A separate analysis was also performed with increasing surgeon volume groups to assess the importance of increasing PR volume on in-hospital mortality.
Adjusted regression and mortality assessments were then performed on the case-controlled groups. The outcome variable was in-hospital mortality. P Ͻ 0.05 were considered statistically significant. Logistical regression data were tabulated as odds ratios and 95% confidence interval (CI).
RESULTS

Demographics
One hundred thirty-four HV and 1450 LV surgeons performed 3581 PR in 742 hospitals across 12 states that reported surgeon identifier information over the 8-year period. The median number of states was 8 (range, 4 -9) per year. These 2 procedures accounted for 86% of total PR in the entire NIS database. Distal pancreatectomy accounted for 28.3% of operations while pancreaticoduodenectomy was performed in 71.7% of the cohort (Table  1) . HV surgeons completed more pancreaticoduodenectomies (79%) than distal pancreatectomies (21%). Demographic characteristics of patients who underwent PR are separated by surgeon volume and shown in Table 2 . Compared with LV surgeons, patients who underwent PR by HV surgeons were more likely to be men (49.8% vs. 45.4%), white race (81.1% vs. 74%), elective admissions (87.1% vs. 71.5%), and treated in both teaching 
Patient Outcomes
Unadjusted mortality was lower among patients undergoing PR by HV surgeons (2.6% vs. 6.7%). Likewise, median length of stay (11 vs. 13 days) was lower for patients of HV surgeons (P Ͻ 0.0001) but there was no difference in-hospital charges between the 2 groups. Increasing surgeon volume (by increments of 5 PR) per year resulted in cumulative improvement in in-hospital mortality (Fig. 2 ). This analysis further validates the use of 5 PR per year as the cut-off of HV and LV surgeons in this analysis. Five PR per year seems to be the cut-off at which point mortality reaches an acceptable rate of 2% to 3% in-hospital mortality.
The effect of independent variables on in-hospital mortality was evaluated using a multivariate logistical regression with results summarized in Table 3 . Factors that correlated with increased mortality included: advanced age (HR: 1.06, 95% CI: 1.03-1.08), Medicaid (HR: 2.64, 95% CI: 1.16 -6.01), and undergoing pancreaticoduodenectomy (HR: 1.96, 95% CI: 1. 18 -3.24) . Factors that demonstrated a protective effect on mortality were: female sex (HR: 0.62, 95% CI: 0.44 -0.88), treatment in a teaching hospital (HR: 0.69, 95% CI: 0.47-1.00), or HV hospital (HR: 0.53; 95% CI: 0.32-0.89), and HV surgeon (HR: 0.44, 95% CI: 0.28 -0.68). A separate analysis using surgeon volume as increasing increments of 5 PR per year resulted in a benefit at higher than 5 PR per year (6 -10 PR/yr: HR: 0.35, 95% CI: 0.15-0.83) but not at higher cut-points (11-15 PR/yr: HR: 0.67, 95% CI: 0.29 -1.52; Distal pancreatectomy and pancreaticoduodenectomy were also analyzed individually due to differences in the complexity of each procedure. There was no difference in demographics or univariate outcomes when each procedure was examined. In addition, analysis of each procedure individually did not affect the volume relationship.
Adjusted Mortality Models
Propensity groups successfully eliminated the influence of patient characteristics on outcome as distributions of measure variables were similar between groups. Many factors which were independently associated with mortality in the unadjusted cohort were no longer important factors for in-hospital mortality. Demographics of the propensity cohort are shown in Table 4 . Adjusted mortality was 2.4% with HV surgeons compared with 6.4% with LV surgeons (P Ͻ 0.001). Logistical regression of propensity matched groups was then performed and summarized in Table 5 . Advanced age (HR: 1.04 CI: 1.01-1.07 P ϭ 0.002) and pancreaticoduodenectomy (HR: 1.96 CI: 1.00 -3.85 P ϭ 0.05) were the only factors studied which trended toward independent risk factors for in-hospital mortality. Only PR performed by a HV surgeon was associated with decreased mortality independent of patient factors (HR: 0.49 CI: 0.28 -0.83 P ϭ 0.009). Using a previously validated formula, HV hospital was responsible for 19% of the benefit of operation by HV surgeon. 1
DISCUSSION
Our results confirm that there are significant differences in the patient populations after PR by HV and LV surgeons in this cohort of the NIS. Most notably race and urgency of admission differed between the groups. Compared with LV surgeons, HV surgeons were also more likely to operate in both teaching and large bed size hospitals. After logistic regression independent factors associated with mortality included: advanced age, male sex, Medicaid insurance, and pancreaticoduodenectmy versus distal pancreatectomy. As in other studies, unadjusted mortality was lowest among HV surgeons, however, it is possible that this result was influenced by the disparate patient populations between surgeon groups. 1 For this reason, propensity matched groups were created to reduce such differences among patient groups. The protective effect of HV surgeons on patient outcomes remained despite controlling for patient factors.
The relationship between center and surgeon remains to be further elucidated. We found that center volume clearly has some effect on surgeon outcomes but it was not as great as we had initially suspected or previously reported. 1 Using a previously validated method by Birkmeyer et al, 1 we estimated the impact of surgeon and center as confounding variables. In the unadjusted cohort, hospital volume was "responsible" for 27% of the benefit observed in HV surgeons performing PR. This benefit decreased to 19% in the propensity matched group. The independent benefit of HV surgeons persisted even when HV hospitals were included in the analysis.
There has been a national trend in complex surgery to centralize care based on studies showing improved outcomes at HV centers and by HV surgeons. 18 -23 The implications of centralizing complex surgical care and limiting it to HV surgeons and centers are significant. In our study, LV surgeons accounted for more PR than HV surgeons; therefore, if strict volume guidelines were implemented, LV surgeons would be impacted by lack of complex surgery or would need to increase their caseload (Table 1) . Several studies have suggested that PR is underutilized in acceptable surgical candidates. 24, 25 Riall et al demonstrated that in Texas a significant portion of PR, 25% to 35%, occur in LV centers (Ͻ5 PR/yr) and that long distance from HV centers led to decreased PR in appropriate candidates. 26 If PR is already underutilized and much of the resections that occur do so in LV centers, centralization of care could create more barriers to patients receiving resection. Perhaps the most concerning implication of centralization involves access to a HV facility. It has been shown in a California study that blacks and Hispanics are treated less often at HV centers for complex surgery. 27 When this is combined with our finding that HV surgeons operate less on ethnic minorities including blacks and Hispanics, centralization could exacerbate access to pancreatic surgery for underserved populations. This would likely lead to later diagnosis and some avoidable deaths.
We set cut-offs at 5 PR per year to create equal volume groups. This is a validated methodology but perhaps not the best determinant of volume. 28, 29 To test the robustness of our volume cut-offs, we also tested increasing volume increments of 5 PR per year. In an unadjusted mortality analysis we found that after 5 PR per year mortality significantly decreased with increasing volume groups (2%-3% vs. 6.7% in-hospital mortality). Incorporating these incremental volume groups in a separate regression model validated this result. Although 5 PR per year may seem too low to most pancreatic specialists, it reflects the large number of surgeons performing 1 or 2 PR per year in the US. We acknowledge that increasing volume groups (eg, 11-15, 16 -20 , Ͼ20 cases/yr) may not have reached statistical significance due to type II error. Our work supports the idea that centralization of such procedures like PR may be prudent and it suggests a realistic volume for PR per year (n ϭ 5), which would be possible to implement if centralization was to occur. Centralization of high risk surgery like PR will demand a means to assure access for underserved populations.
Mortality in pancreatic surgery varies between studies as rates for pancreaticoduodenectomy range from 0% to 28%. 30 At HV centers mortality rates for PR have been shown to be less than 5% ranging from 0% to 4% depending on the center. 18, [31] [32] [33] In a previous analysis of the NIS, McPhee et al showed that between 1998 and 2003 mortality rates for pancreatectomy decreased from 8.2% to 5.5%. 2 Our results are in line with previously reported database studies but do show a dramatic difference between HV and LV surgeons in the unadjusted cohort as well as the propensity matched groups.
A previous study by Birkmeyer et al showed surgeon volume to be a protective factor in Medicare patients undergoing complex surgery like pancreatic surgery. 1 In that study attempts were made to control for patient characteristics between groups, however, propensity scores were not used. Other reports have also shown the benefits of HV providers in PR after controlling for patient characteristics using state inpatient data. 34, 35 The use of propensity scores allowed us to create case controlled groups and evaluate the independent factor of surgeon volume knowing that patient characteristics were similar between groups. After propensity score matching, there were no clinically or statistically significant differences between cohorts except for surgery at a teaching hospital. Although this method accounts only for known confounders, it represents an extensive list of variables and therefore it is unlikely that an unaccounted for confounder would have a substantial effect on our results. Our study used one of the largest databases of patient discharges and therefore our cohort was not limited to Medicare recipients, a group which our study shows may be at increased risk of mortality in PR to begin with.
Limitations of this study do exist and should be considered when interpreting the results. As a retrospective study, we are limited to the NIS database and cannot confirm the procedure codes or other information as patient identifiers do not exist in the database. The data compiled in the NIS is limited and insufficient to more closely examine the hospital course of PR patients which could influence outcomes of individual cases. Only in-hospital mortality was measured in this study and mortality after discharge most certainly can be related to PR but are missed by our study. Despite being the largest all-payer database of hospital discharge records in the United States, there is no guarantee that our cohort is representative of local demographics and surgeon practices which may vary by state and community. In this study, only states that had accurate surgeon and hospital identifiers were included in the study. These states reflected a large sample or diverse states across the country and therefore we felt that it was a representative sample of the United States. Despite their strengths, propensity scores cannot account for selection bias related to unmeasured characteristics.
In summary, our study confirms improved outcomes for HV surgeons performing PR. Our study suggests that the benefit is extremely robust and is maintained after controlling for independent patient factors. This supports the premise that improved outcomes may result from centralization of complex surgery. Since one-fifth of the mortality benefit enjoyed by HV surgeons is likely due to hospital factors, a complex interplay between surgeon and hospital volume exists. Centralization will likely improve outcomes because both surgeon and hospital volume will be optimized in that setting. Before guidelines specifying which surgeons and centers can provide complex surgical care, a more complete analysis of the relationship between survival benefit and volume is needed as patient factors may have inflated the survival benefit of operation by HV surgeons in prior studies. Careful consideration of the unintended consequences of centralization must also occur before changes are made to insure equal access to lifesaving surgical interventions.
